General Mills earnings up next: Can volume recovery offset GLP-1 fears?

General Mills reports Q4 earnings after the open with consensus EPS of 80.6 cents and revenue of $4.58B (both essentially flat YoY), after a prior-quarter miss (64 cents EPS; $4.40B revenue). The stock faces a sentiment overhang from downgrades that pushed price targets down to roughly $30–32 from as high as $44, and management must prove that a ~3% price reduction across key brands has stabilized volumes. The bigger risk is GLP-1 adoption (12.4% of Americans vs. 5.8% early 2024), which research links to 5.3% lower grocery spending and 10.1% lower savory snack purchases—raising pressure on cereal/snack categories and making FY2027 guidance the key catalyst.

Analysis

The key market mechanism is not a one-quarter miss; it is whether legacy center-store brands are entering a lower-growth regime where price cuts only buy share from private label, not category demand. If volume remains negative after an extended reset, the industry implication is that KHC, CPB, MDLZ and even retailer-owned brands will compete harder on promo, compressing gross margin and making FY27 margins less levered to inflation normalization than investors expect.

The bigger second-order effect is mix migration: GLP-1 adoption shifts spend away from shelf-stable carbs toward protein, fresh, and smaller baskets, which structurally hurts GIS more than companies with condiment, beverage, or indulgence exposure. That is a multi-quarter headwind, not a day-of-earnings issue; the near-term risk is management avoids a hard reset, but the real catalyst is FY27 guidance. A soft guide would likely force estimate cuts again and keep the stock trapped in a low-multiple value trap despite cheap trailing earnings.

Consensus may be underestimating how little downside protection the valuation provides if earnings power is revised down another 10-15%. The bullish case needs proof of elastic demand recovery, not just better reported EPS from mix or cost cuts. What would falsify the bearish thesis is a clean inflection in organic volume and a management narrative that innovation is scaling fast enough to offset category shrinkage within 1-2 quarters, rather than a one-off quarter of price realization.

Key Decisions for Investors

• Short GIS into the print or use a post-earnings rally to enter; target is a re-rating toward the low-$30s if FY27 guidance implies another cut to core EPS. Falsify on positive organic volume and explicit FY27 stabilization language.
• Pair trade: short GIS / long KHC over 1-3 months. GIS has higher exposure to GLP-1-sensitive carb categories, while KHC’s mix is less dependent on cereal/dough volume recovery; use the spread to isolate category-specific demand risk.
• Buy GIS puts only if implied volatility remains below the stock’s likely guide-reset risk; prefer 1-3 month tenor centered on the earnings date. Risk/reward improves if management fails to defend volume and gives cautious FY27 commentary.
• Watch for read-through to MDLZ and CPB rather than treating this as company-specific. If GIS volumes disappoint, expect pack-food promo intensity to rise across the group, which can cap upside for sector longs even if reported EPS holds up near term.